Aberrant expression in lymphoma, a diagnostic pitfall

被引:1
|
作者
Song, Joo Y. [1 ]
Pan, Zenggang [2 ]
机构
[1] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA
[2] Univ Colorado, Sch Med, Dept Pathol, 12605 East 16th Ave, Aurora, CO 80045 USA
关键词
Aberrant expression; B-cell lymphoma; T-cell lymphoma; Hodgkin lymphoma; B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CLASSICAL HODGKINS LYMPHOMA; PRIMARY-EFFUSION-LYMPHOMA; CYCLIN D1 EXPRESSION; BONE-MARROW BIOPSY; T-CELL; PROGNOSTIC-SIGNIFICANCE; CYTOKERATIN EXPRESSION; ADHESION MOLECULE;
D O I
10.1016/j.humpath.2024.105706
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
One of the major difficulties in practical hematopathology is to accurately assign cell lineage and thus ensure proper classification of lymphomas. The lineage-specific markers of lymphoma are detected by immunohistochemistry or flow cytometry immunophenotypic methods. However, aberrant gain or loss of these markers is occasionally encountered during daily practice, which often creates diagnostic challenges. In addition, lymphoma may aberrantly express non-hematopoietic markers, and vice versa. This review article provides an overview of aberrant gain of expression of lineage-associated antigens in mature lymphoid neoplasms, including recommendations to avoid diagnostic pitfalls and ultimately to reach accurate diagnoses.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Ocular mantle cell lymphoma with aberrant CD10 expression: a potential diagnostic pitfall
    Lian, Derrick Wen Quan
    Chau, Yuk Ping
    Lee, Llewellyn Kuan Ming
    Teo, Clarence
    Yap, Wai Ming
    Chuah, Khoon Leong
    PATHOLOGY, 2009, 41 (07) : 704 - 706
  • [2] Thymoma with aberrant expression of CD20: a potential diagnostic pitfall of B-cell lymphoma
    Wei, Qing
    Bueso-Ramos, Carlos E.
    BLOOD, 2024, 143 (15) : 1551 - 1551
  • [3] Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
    Dhonye, Yasin
    Saadi, Haifaa
    Arqoub, Hadil Abu
    Al-Qsous, Wael
    EJHAEM, 2023, 4 (01): : 282 - 283
  • [4] Aberrant expression of neuroendocrine markers in angiosarcoma: a potential diagnostic pitfall
    Cloutier, Basile Tessier
    Costa, Felipe D'Almeida
    Tazelaar, Henry D.
    Folpe, Andrew L.
    HUMAN PATHOLOGY, 2014, 45 (08) : 1618 - 1624
  • [5] Aberrant Pattern of Cytokeratin Expression in Olfactory Neuroblastoma: A Potential Diagnostic Pitfall
    Martina Mandarano
    Renato Colella
    Michele Giansanti
    Angelo Sidoni
    Head and Neck Pathology, 2017, 11 (2) : 262 - 263
  • [6] Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors
    Huang, Michelle
    Sakhdari, Ali
    EJHAEM, 2022, 3 (04): : 1433 - 1434
  • [7] Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: A diagnostic pitfall
    Yao, X
    Teruya-Feldstein, J
    Raffeld, M
    Sorbara, L
    Jaffe, ES
    MODERN PATHOLOGY, 2001, 14 (02) : 105 - 110
  • [8] Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall
    Shah, Sejal S.
    Wu, Tsung-Teh
    Torbenson, Michael S.
    Chandan, Vishal S.
    HUMAN PATHOLOGY, 2017, 64 : 13 - 18
  • [9] "Aberrant" expression of skeletal muscle markers in neuroendocrine carcinomas: a significant diagnostic pitfall
    Garcia-Porrero, Guillermo
    Wood, Faye
    Faria, Sara
    Kelly, Paul J.
    Mccluggage, W. Glenn
    VIRCHOWS ARCHIV, 2024, 485 (04) : 625 - 629
  • [10] Aberrant TdT Expression in Germ Cell Neoplasia-A Pitfall in Differential Diagnosis With Lymphoma?
    Gayhart, Matthew
    Smith, Steven
    Wiles, Austin
    Richard, Hope
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S32 - S33